Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;34(4):e15023.
doi: 10.1111/dth.15023. Epub 2021 Jun 10.

The multi-target mechanism of Cyclosporin A in the treatment of vitiligo based on network pharmacology

Haojie Lu  1 , Jinhui Xu  1 , Bo Xie  2 , Yebei Hu  1 , Haixin Luo  1 , Yi Chen  1 , Xiuzu Song  2
Affiliations

The multi-target mechanism of Cyclosporin A in the treatment of vitiligo based on network pharmacology

Haojie Lu et al. Dermatol Ther. 2021 Jul.

Abstract

Network pharmacology is an emerging discipline that designs drugs based on systems biology theory and biological system network analysis. Here, we applied network pharmacology to analyze the multi-target mechanism of Cyclosporin A in the treatment of vitiligo First, we predicted the targets of Cyclosporin A. Second, we obtained the genes related to vitiligo from the database. Third, we constructed the PPI network of the mutual genes between Cyclosporin A and vitiligo and used gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) to analyze. Finally, we verified the prediction of potential targets through a docking study with Cyclosporin A. We found that there were 15 shared target genes between Cyclosporin A and vitiligo. We analyzed these 15 genes by Cytoscape and obtained a network diagram of 885 nodes. Through screening and molecular docking, PRKDC, CUL7, CUL1, HSPA8, HSPA4, and SIRT7 were the most likely multi-target mechanism of Cyclosporin A in the treatment of vitiligo. In our study, Cyclosporin A might not only affect the repair of DNA strands by targeting PRKDC, but also affected the innate and adaptive immune function of vitiligo patients by the targets of CUL1, CUL7, and HSP70. In addition, Cyclosporin A might promote the repigmentation of vitiligo by adjusting the expression of SIRT7.

Keywords: Cyclosporin A; multi-target mechanism; network pharmacology; treatment; vitiligo.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

REFERENCES

    1. Yaghoobi R, Omidian M, Bagherani N. Vitiligo: a review of the published work. J Dermatol. 2011;38(5):419-431.
    1. Lili Y, Yi W, Ji Y, Yue S, Weimin S, Ming L. Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo. PLoS One. 2012;7:e37513.
    1. Taneja A, Kumari A, Vyas K, Khare AK, Gupta LK, Mittal AK. Cyclosporine in treatment of progressive vitiligo: an open-label, single-arm interventional study. Indian J Dermatol Venereol Leprol. 2019;85:528-531.
    1. Mutalik S, Shah S, Sidwadkar V, Khoja M. Efficacy of cyclosporine after autologous noncultured melanocyte transplantation in localized stable vitiligo: a pilot, open label, comparative study. Dermatol Surg. 2017;43:1339-1347.
    1. Császár T, Patakfalvi A. Treatment of polyglandular autoimmune syndrome with cyclosporin A. Acta Med Hung. 1992;49:187-193.

Publication types